TRANSENTERIX INC's ticker is TRXC and the CUSIP is 89366M201. A total of 153 filers reported holding TRANSENTERIX INC in Q4 2018. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $168,000 | -51.3% | 271,400 | +7.1% | 0.00% | – |
Q2 2019 | $345,000 | -18.4% | 253,500 | +42.7% | 0.00% | – |
Q1 2019 | $423,000 | +14.0% | 177,700 | +8.2% | 0.00% | – |
Q4 2018 | $371,000 | -61.1% | 164,300 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $953,000 | +39.1% | 164,300 | +4.6% | 0.00% | – |
Q2 2018 | $685,000 | +2754.2% | 157,000 | +685.0% | 0.00% | – |
Q1 2017 | $24,000 | -7.7% | 20,000 | 0.0% | 0.00% | – |
Q4 2016 | $26,000 | -23.5% | 20,000 | 0.0% | 0.00% | – |
Q3 2016 | $34,000 | 0.0% | 20,000 | -28.3% | 0.00% | – |
Q2 2016 | $34,000 | -33.3% | 27,900 | +130.6% | 0.00% | – |
Q1 2016 | $51,000 | +70.0% | 12,100 | 0.0% | 0.00% | – |
Q4 2015 | $30,000 | +11.1% | 12,100 | 0.0% | 0.00% | – |
Q3 2015 | $27,000 | -25.0% | 12,100 | 0.0% | 0.00% | – |
Q2 2015 | $36,000 | +500.0% | 12,100 | +450.0% | 0.00% | – |
Q1 2015 | $6,000 | 0.0% | 2,200 | 0.0% | 0.00% | – |
Q4 2014 | $6,000 | -40.0% | 2,200 | 0.0% | 0.00% | – |
Q3 2014 | $10,000 | -54.5% | 2,200 | -50.0% | 0.00% | – |
Q2 2014 | $22,000 | – | 4,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 7,546,692 | $12,829,000 | 9.62% |
StepStone Group LP | 3,032,625 | $5,155,000 | 3.79% |
Aisling Capital LLC | 9,889,352 | $16,812,000 | 3.00% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 519,548 | $883,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 889,082 | $1,503,000 | 0.59% |
MASTERS CAPITAL MANAGEMENT LLC | 4,000,000 | $6,800,000 | 0.15% |
Tibra Equities Europe Ltd | 335,565 | $570,000 | 0.10% |
BRANDYWINE MANAGERS, LLC | 94,583 | $161,000 | 0.09% |
SABBY MANAGEMENT, LLC | 513,430 | $872,000 | 0.05% |
ACUTA CAPITAL PARTNERS, LLC | 180,000 | $307,000 | 0.05% |